Market Closed -
Other stock markets
|
Pre-market 07:00:11 am | |||
49.14 USD | +0.43% | 49.18 | +0.08% |
11:29am | Novartis Nominates Former Bristol Myers Squibb CEO as New Chair | MT |
11:12am | Novartis Lifts 2024 Guidance as First-quarter Earnings Grow on Strong Blockbuster Drug Demand | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.23% | 99.59B | |
+25.46% | 659B | |
+26.83% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.43% | 215B | |
+7.64% | 210B | |
-6.01% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb : Goldman Sachs Upgrades Bristol-Myers Squibb to Conviction Buy From Buy, Raises PT to $86 From $82; Shares Rise 3%